Fundz

Advanced NanoTherapies raised over $31M in Series B funding led by S3 Ventures to scale manufacturing and advance clinical trials.

PRIVATEJun 02, 2026

Amount Raised

$31 Million

Round Type

Series B

Los GatosManufacturingBiotechnologyHealth CareScience And Engineering

Investors

T45 FundS3 Ventures

Description

Advanced NanoTherapies, a developer of a nanoparticle-coated dual-drug balloon platform for vascular treatment, raised over $31M in Series B funding. The round was co-led by an undisclosed strategic investor and S3 Ventures, with participation from T45 Fund and others. The company plans to use the funds for manufacturing capabilities and clinical trials. They have also secured FDA breakthrough designation for their lead program.

Quick answer

Advanced NanoTherapies raised $31 Million in a Series B round, dated June 2, 2026. Investors: T45 Fund and S3 Ventures. Advanced NanoTherapies is based in Los Gatos, California, United States.

How much did Advanced NanoTherapies raise?
Advanced NanoTherapies raised $31 Million in a Series B round on June 2, 2026.
Who invested in Advanced NanoTherapies?
T45 Fund and S3 Ventures are named as investors in this round.
What does Advanced NanoTherapies do?
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention.
Where is Advanced NanoTherapies based and how big is it?
Advanced NanoTherapies is based in Los Gatos, California, United States. Fundz records about 17 employees.
Who are the decision-makers at Advanced NanoTherapies?
Fundz holds 1 contact at Advanced NanoTherapies. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Manufacturing around the same time

Companies in the same sectors as Advanced NanoTherapies that raised within 45 days of this round, from Fundz verified event records.

  • RedHill Biopharma Ltd raised $6M (Post-IPO Equity) on June 18, 2026.
  • Endo Tools Therapeutics raised $23M (Series C) on July 16, 2026.
  • Mauna Kea Technologies raised $4.6M (Debt Financing) on July 15, 2026.
  • Precision Peptide Company raised $883K (Seed) on July 14, 2026.
  • IM Cannabis Corp raised $225K (Convertible Note) on July 13, 2026.
  • GMP Manufacturing Ltd raised $667K (Debt Financing) on July 8, 2026.

Who to call at Advanced NanoTherapies, and when

A new round usually means Advanced NanoTherapies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Advanced NanoTherapies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Advanced NanoTherapies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Advanced NanoTherapies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Advanced NanoTherapies

Location

Los Gatos, California, United States

About

AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Advanced NanoTherapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Advanced NanoTherapies. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Advanced NanoTherapies's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Advanced NanoTherapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.